Supply Chain Management (SCM) Market is estimated to rise at 11.4% CAGR between 2021 – 31

The supply chain management (SCM) market solutions revenue totaled ~US$ 19.5 Bn for 2020, according to Future Market Insights’ (FMI’s) latest study. The overall market is expected to reach ~US$ 62.6 Bn by 2031, growing at a CAGR of 11.4% for 2021 – 31. The demand for supply chain management solutions will accelerate with top 5 providers holding around 50.2% of total market in 2020.

Newly released data on the supply chain management demand outlook indicates 8.7% y-o-y growth in 2021. Among industry verticals, the market share for retail & consumer goods sector is the largest among all. However, the transportation & logistics segment will grow at 14.6% CAGR to emerge as the fastest growing end user through the assessment period.

Get a Free Sample Copy of Report with TOC, Graphs & List of Figures@ https://www.futuremarketinsights.com/reports/sample/rep-gb-13958

Increasing demand for supply chain management (SCM) market solutions from both large enterprises and small and medium enterprises (SMEs), growing awareness about the benefits offered by SCM solutions, including supply chain optimization, forecasting accuracy, meaningful synthesis of business data, and wastage minimization are likely to fuel the demand for supply chain management solutions over the coming years.

The SCM sales is estimated to rise at 11.4% CAGR between 2021 and 2031 in comparison with 8.6% CAGR registered during 2016-2020. The global supply chain management growth scenario is anticipated to witness an increase in revenue from ~US$ 21.2 Bn in 2021 to ~US$ 62.6 Bn by 2031.

“Supply chain management solutions enable organizations to efficiently manage potential challenges such as demand spikes, inventory and labor shortages, and transportation disruptions, along with effectively mitigating supply chain disturbances. In addition to this, agility and omnichannel supply chains are becoming the norm, while the increasing availability of Big Data means organizations are now able to close the loop with prescriptive analytics and make informed supply chain decisions,” says FMI analyst.

Chief factors fueling the demand for supply chain management solutions include high growth in eCommerce, need for greater transparency and visibility in supply chain processes and data, enhancing business continuity by minimizing potential failures, and rising adoption of cloud supply chain management among SMEs.

Get Customization on this Report for Specific Country: https://www.futuremarketinsights.com/customization-available/rep-gb-13958

Key Takeaways: Supply Chain Management Market
• By software solution segment, the integrated SCM platform/suite is anticipated to account for the leading market share. The segment is estimated to grow at a robust CAGR of 13.5% through 2031.
• Based on deployment, the on-premises segment is estimated to account for more than half of the software solution segment in 2021.
• The demand for supply chain management in large enterprises is expected to grow at the highest rate.
• Demand for supply chain management in transportation & logistics and manufacturing sector is estimated to grow at an impressive CAGRs. However, retail & consumer goods segment is estimated to continue to hold dominant market share in the global supply chain management market during the forecast period.
• Among the regions, North America is estimated to hold highest market share followed by Europe in 2021. South Asia & Pacific is anticipated to emerge as the fastest growing region between 2021 & 2031.
• The market in Japan is expected to progress at a noteworthy CAGR of more than 14% through 2031.
• In the U.K., sales are expected to increase tremendously at a CAGR of 11.4% over the next ten years.

COVID-19 Impact Analysis on Supply Chain Management Market
The COVID–19 pandemic has compelled several industries and organizations to revamp their global supply chain model. The lockdown implemented to contain the spread of the virus across various countries has shut down economies and is impacting every aspect of the supply chain around the world.
The global pandemic affected almost all aspects of the global economy over the past few months. One industry that has seen remarkable changes is e-commerce.

There is a huge pressure on the supply chain logistics industry to keep up with the ever-rising demand, as self-isolated consumers are shifting towards online shopping platforms. Accordingly, logistics companies are stepping up with innovative strategies to respond to these rapidly shifting logistics trends in 2021.

Contact Sales for Further Assistance in Purchasing this Report- https://www.futuremarketinsights.com/checkout/13958

Competitive Landscape
Some of the leading companies in this landscape are IBM Corporation, Oracle, SAP SE, Manhattan Associates, and E2open LLC among others. As per Future Market Insights, nearly 60% of the market share is currently covered by the top 15 players.

About FMI
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth.

Contact Us:
Future Market Insights
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Disposable Laparoscopic Instruments Market Trends, Growth, Future Demand, Analysis and Forecast by 2028

This Future Market Insights report examines the ‘Disposable Laparoscopic Instruments Market: Global Industry Analysis 2013 – 2017 and Opportunity Assessment, 2018 – 2028. The primary objective of the report is to offer updates and insights regarding the various market opportunities in the global disposable laparoscopic instruments market.

Laparoscopy is a minimally invasive surgical technique performed through a keyhole incision. A small camera along with a light source attached to a tube enables surgeons to manoeuvre special disposable laparoscopic instruments to the target area and carry out the surgery. This technique is mainly preferred for carrying out surgeries related to the pancreas, liver, colon and bile duct. The use of disposable laparoscopic instruments reduce the risk of infection during surgery. Laparoscopic surgery refers to surgical procedures that are performed through one or multiple small incisions, rather than through a larger incision through the abdominal wall. Depending upon the nature of the specific surgical procedure, laparoscopic entry can be performed using a closed (Veress needle, optical access) or open technique (Hasson technique). Disposable laparoscopic instruments find applications for various other surgeries such as general surgery, bariatric surgery, colorectal surgery, urologic surgery, gynaecologic surgeries and others.

To provide an accurate understanding and to assess the opportunities in this market, the report is categorically split under three sections, namely market analysis by product type, indication, end-use and regions. The report analyses the global disposable laparoscopic instruments market in terms of market value (US$ Mn).

The report starts with an overview of disposable laparoscopic instruments and usage in applications in regions across the globe. In the same section, FMI covers the disposable laparoscopic instruments market performance in terms of revenue. This section includes, FMI’s analysis of key trends, drivers and restraints from supply side and demand side perspective.

The next section of the report analyses the market based on product type and presents the forecast in terms of value for the next 10 years. The product types of disposable laparoscopic instruments covered in the report include:

  • Laparoscopic Scissors
  • Laparoscopic Hooks
  • Grasping Forceps & Dissectors
  • Trocars
  • Laparoscopic Suction / Irrigation Devices
  • Others

Any Queries Regarding Report, Ask Us @ https://www.futuremarketinsights.com/ask-question/rep-gb-3166

The next section of the report analyses the market based on indication segments and presents the forecast in terms value for the next 10 years. The indications for disposable laparoscopic instruments market segments covered in the report include:

  • General Surgery
  • Bariatric Surgery
  • Colorectal Surgery
  • Urology Surgery
  • Gynecologic Surgeries
  • Others

The next section of the report analyses the market based on end-use segments and presents the forecast in terms value for the next 10 years. The end-use for disposable laparoscopic instruments market segments covered in the report include:

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics

The next section of the report analyses the market based on regions and presents the forecast in terms of value for the next 10 years. The regions covered in the report include:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific excluding Japan (APEJ)
  • Japan
  • Middle East & Africa (MEA)

To arrive at market size, the report considers average price of disposable laparoscopic instruments across geographies. The forecast presented in the report assesses the total revenue of the disposable laparoscopic instruments market. When developing the market forecast, the first job is sizing the current market, which forms the basis for the forecast of how the market is expected to take shape in the near future. Given the characteristics of market, we triangulated the outcome based on different analysis based on supply side, demand side and GDP growth rate. However, quantifying the market across aforementioned segments and regions is more a matter of quantifying expectations and identifying opportunities, rather than rationalizing them after the forecast has been completed.

In addition, we have taken into consideration year-on-year growth to understand the predictability of the market and to identify the right opportunities across the market.

As previously highlighted, the market for disposable laparoscopic instruments is split into various sub-segments based on region, product type, indication and end-use. All these sub-segments or categories have been analysed to understand individual segments’ relative contribution to the growth. This detailed level of information is important for identification of the many key trends in the disposable laparoscopic instruments market.

Also, another key feature of this report is the analysis of disposable laparoscopic instruments market by regions, product types, indication and end use. Its revenue forecast in terms of absolute dollar value is traditionally overlooked while forecasting the market. However, absolute dollar opportunity is critical in assessing the level of opportunity that a provider can look to achieve, as well as to identify potential resources from a sales perspective. Furthermore, Future Market Insights has developed market attractiveness index for all the four segments – regional, product type, indication and end use. This index helps in identifying the real opportunities available in the market.

In the final section of the report, the disposable laparoscopic instruments market landscape is included to provide report audiences with a dashboard view, based on categories of providers across the market.

Request Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-3166

Reasons to Buy the report

  • We provide authentic and detailed an analysis on various market trends to enable businesses to make informed and beneficial decisions to attain competitive edge over key players.
  • Our analysts provide detailed market segmentation along with meaningful insights and extensive reports that other companies fail to include.
  • The report includes accurate analysis of the market and the current developing trends affecting the growth. FMI speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, industry experts. This ensures that the data collected is from highly reliable sources.

Why Future Market Insights?

  • Comprehensive analysis on evolving purchase pattern across different geographies
  • Detailed insights of market segments and sub-segments for historical as well as forecast period
  • A competitive analysis of prominent players and emerging players in the Disposable Laparoscopic Instruments Market
  • Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years
  • Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact:
Future Market Insights,
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com/

Amniotic Membranes Market is anticipated to exhibit 9.3% CAGR for heading towards an estimate of nearly US$ 2,322.6Mn by the end of 2028

Increasing regulatory approvals on products, demographic change related to aging population, rising awareness regarding the presence of cytokines and growth factors in amniotic membrane has been driving the growth of overall amniotic membrane market. Demand for advanced surgical healing to increase the production sales of amniotic membrane across the globe in the near future. Rapid developments with regards to tissue preservation methods are expected to stimulate towards the growth of amniotic membrane market in the near future.

A holistic research has been carried out by a research company named Future Market Insights on the report titled, amniotic membrane market. All the end-users are likely to gain profit with the help of this in-depth analysis that has been carried out by our analysts. The report has displayed that amniotic membrane market is anticipated to exhibit 9.3% CAGR for heading towards an estimate of nearly US$ 2,322.6Mn by the end of 2028.

A sample of this report is available upon request @ https://www.futuremarketinsights.com/reports/sample/rep-gb-5044

The research company is of the viewpoint that developing technologically finest, innovative and advanced amniotic membrane will possibly be taken up as a rising trend that would be notably lucrative for the expansion of amniotic membrane market worldwide. Analysts comprehensively involved in the development of this report have been working towards catering to the emerging as well as existing concerns of market observers and industry competitors related to the overall amniotic membrane market.

What are the manufacturers focused on relating to the expansion of amniotic membrane market?

Manufacturers have been working with the key players to focus on development of innovative products, creating market level strategies for the purpose of leveraging potential opportunities that is expected to rise due to rapid growth in population with several chronic diseases across the globe.

List down the important factors responsible for fuelling the growth of amniotic membrane market.

Analysis indicates that rising number of the geriatric population, increasing cases of transplants regarding amniotic membrane, rising focus on tissue, which is stem cell and cell research as well as rapid growth in R&D investments relating amniotic membrane transplantation have been responsible for fuelling the growth of amniotic membrane market.

List down the important factors responsible for hampering the growth of amniotic membrane market.

Analysis indicates that lack of skilled professionals for performing amniotic membrane transplantation as well as lack of availability of standardized guidelines related to bio-medical engineering and tissues have been hampering the growth of amniotic membrane market.

What is your perspective about the regions in amniotic membrane market?

Well, North America is expected to hold the lion’s share in amniotic membrane market during the forecast period. Besides, APEJ and Western Europe are likely to create noteworthy growth avenues for the amniotic membrane market in the coming years.

List the names of main companies operating in the amniotic membrane market.

Analysts after the in-depth analysis have come across Applied Biologics LLC, MiMedx Group, Inc., Integra LifeSciences Holdings Corporation, Amnio Technology, LLC, Katena Products, Inc., and Tissue-Tech Inc. and Skye Biologics Inc. among others as the main companies operating in the amniotic membrane market.

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact:
Future Market Insights,
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com/

Prurigo Nodularis Treatment Market Size, Share, Growth Trends, and Forecast Analysis to 2030

Prurigo nodularis indicates a skin condition in which hard, itchy nodules or lumps develop on the skin surface. This condition can vary from mild to severe case and it is categorised under the chronic inflammatory rare disease of unknown aetiology. Advancements of diagnostics technology and diagnosis seeking rate are expected to boost prurigo nodularis treatment market growth. Future Market Insights (FMI), the market will exhibit 3% Y-o-Y growth in 2021. With prevalence of the disease forecast to rise, accelerated demand is likely in the near future.

Leading market players are currently focusing on strategic collaborations with various healthcare institutes, universities, governmental agencies, start-up organizations and industry suppliers. This is intended to expand their footprint as well as drive various research and development initiatives.

Besides efforts by market players, initiatives undertaken by regulatory bodies to improve the development and approval process of orphan drug will aid the overall prurigo nodularis treatment market growth. According to FMI, the capsaicin cream segment by drug class is anticipated to gain the momentum significantly contributing towards market growth in the coming years. It is expected to account for over 40% of the market in 2020.

Key Takeaways from Prurigo Nodularis Treatment Market Study

  • The demand from the U.S. is expected to rise at a steady pace. It is expected to account for over 91% of the North America market
  • France will emerge as a lucrative market, registering above 3% Y-o-Y growth in 2021
  • The U.K. and Germany will emerge as other key markets for prurigo nodularis treatment in Europe
  • Within East Asia, Japan and China will record rising demand for Prurigo nodularis treatment.

“Increasing research and development activities are expected to boost the growth for prurigo nodularis treatment market. On the other hand, there is high prevalence of unmet needs in the therapeutic domain of rare diseases. This will create impressive growth opportunities for key players contributing towards growth of the market” says the FMI Analyst 

Get Report Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-3339

Who is Winning?

The global market is set to expand steadily over the forecast period, driven by the increasing prevalence of prurigo nodularis, advancements in technology, and adoption of prurigo nodularis treatment drugs which can be used for long term care needs. In addition to this, changing regulatory dynamics and lack of adequate knowledge has constrained the sales of prurigo nodularis treatment drugs.

Product approvals by the U. S. Food and Drug Administration (FDA) for prurigo nodularis treatment drugs are expected to push towards high competition among market players. For Instance, in December 2019, Galderma SA announced the breakthrough therapy designation to its drug Nemolizumab from the U.S. FDA for treatment of prurigo nodularis.

Some of the key market players covered by FMI include Bayer AG, Pfizer Inc., GlaxoSmithKline Plc., Teva Pharmaceutical Industries Ltd., Johnson & Johnson Services, Inc., Merck & Co. Inc., Sanofi SA, Takeda Pharmaceutical Company Limited, Novartis AG, Celgene Corporation, Galderma SA (Nestle Skin Health Company), VYNE Therapeutics Inc., Trevi Therapeutics Inc. consolidating their positions through mergers, acquisitions and new product launches.

Want more insights?

Future Market Insights (FMI) brings the comprehensive research report on forecast revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2015 to 2030. The global prurigo nodularis treatment market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights on prurigo nodularis treatment market on basis of drug class such as corticosteroids (injectable, topical, oral), emollients, capsaicin cream, antihistamines, anticonvulsants, antidepressants, neurokinin 1 receptor (NK1R), opiate receptor antagonists and others. And based on distribution channels such as hospital pharmacies, retail pharmacies and online pharmacies across seven major regions.

Any Queries, ask an Expert @ https://www.futuremarketinsights.com/ask-question/rep-gb-3339

Reasons to Buy the report

  • We provide authentic and detailed an analysis on various market trends to enable businesses to make informed and beneficial decisions to attain competitive edge over key players.
  • Our analysts provide detailed market segmentation along with meaningful insights and extensive reports that other companies fail to include.
  • The report includes accurate analysis of the market and the current developing trends affecting the growth. FMI speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, industry experts. This ensures that the data collected is from highly reliable sources.

Explore Wide-ranging Coverage of FMI’s Healthcare Market Insights Landscape

Parasomnia Treatment Market – Parasomnia Treatment Market: Global Industry Analysis 2013 – 2017 and Opportunity Assessment; 2018 – 2028

Trachoma Treatment Market– Trachoma Treatment Market: Global Industry Analysis 2013 – 2017 and Opportunity Assessment; 2018 – 2028

Epiglottitis Treatment Market – Epiglottitis Treatment Market: Global Industry Analysis 2013 – 2017 and Opportunity Assessment; 2018 – 2028

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact:
Future Market Insights,
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com/

Analgesics Market Emerging Industries, Challenges And Threats Faced By Key Vendors And Global Business Outlook Till 2031

As per Future Market Insights’ revised industry analysis, the global analgesics market was valued at over US$ 73.6 Bn in 2020, and is expected to exhibit a CAGR of 5.6% over the forecast period (2021-2031).

Analgesics encompasses a class of drugs that are designed to relieve pain. Different classes of analgesic drugs include opioids, NSAIDs, local anesthetics, and acetaminophen. Analgesics can be administered by various routes such as oral, IV, rectal, topical, and others.

Get Sample of the Report : https://www.futuremarketinsights.com/reports/sample/rep-gb-1306

Increasing number of patients suffering from chronic conditions such as cancer, chronic pulmonary obstructive disease (COPD), as well as increase in post-operative pain management prescription medications and various trauma conditions leading to pain are expected to boost the analgesics market.

Various companies are prioritizing strategic collaborations for the development of non-opioid-based analgesics and an integrated approach towards pain management, prevention of diversion of prescription opioid medications, and the signs of potential abuse or addiction associated with opioid medications.

According to WHO, worldwide, about 0.5 million deaths are attributable to drug use. More than 70% of these deaths are related to opioids, with more than 30% of those deaths caused by overdose. This is a key challenge to the market.

Pfizer is developing non-opioid drugs in partnership with Eli Lilly, and in 2017 Pfizer announced its plans to donate 1 million doses of Naloxone hydrochloride injections to direct relief over four years (up to 250,000 doses per year). This initiative helped to promote the use of non-opioid analgesics for pain management.

Key Takeaways from Market Study

  • By drug class opioids are expected to hold 49.3% market value share by the end of 2031, primarily because of their efficacy in intense pain relief.
  • Based on indication, surgical pain is leading with over 45.9% market share in 2020, owing to rising number of surgical procedures conducted globally.
  • Based on route of administration, oral route holds a dominant share of 37.9% in the global analgesics market.
  • Hospital pharmacies dominated analgesics market with a share of 32.8% in 2020.
  • By region, Europe is slated to be the second-largest leading market with a value share of 25.0% by the end of the forecast period.

“Rising prevalence of chronic and neuropathic pain and development of non-addictive formulations will drive the sales of analgesics over the forecast period” says a FMI analyst.

Competitive Landscape

Acquisitions, mergers, expansion strategies, and product launches are often adopted by manufacturers to gain competitive edge. Some of them are focusing on the development of novel formulations of non-opioid drugs. Besides this, expansion in high potential market will remain key strategy among market players to strengthen their footprint. For instance:

  • In July 2020, Teva Pharmaceuticals decided to expand its operations in the Japan market by focusing on specialty assets and a portfolio of select generics to meet patients’ medical needs.
  • In September 2021, Bausch Health Companies Inc. and its gastroenterology business,Salix Will Share RELISTOR® (Methylnaltrexone Bromide) Data At PAINWeek 2021. RELISTOR® (methylnaltrexone bromide) is an opioid antagonist. RELISTOR tablets and RELISTOR injection are indicated for the treatment of opioid-induced constipation (OIC) in adults with chronic non-cancer pain.

Ask For Regional Data : https://www.futuremarketinsights.com/ask-regional/rep-gb-1306

What Does the Report Cover?

Future Market Insights offers a unique perspective and actionable insights on the Analgesics market in its latest study, presenting historical demand assessment of 2016 – 2020 and projections for 2021 – 2031.

The research study is based on the drug class (opioids, NSAIDs, local anaesthetics and acetaminophen), indication (surgical pain, cancer pain, neuropathic pain and others), route of administration (oral, parenteral, transdermal and others), distribution channel (hospital pharmacies, retail pharmacies, drug stores and online pharmacies), across seven key regions of the world.

Teleradiology Market are likely to surge at a vigorous 12.18% CAGR during the assessment period

As per a study by ESOMAR-certified consulting firm Future Market Insights (FMI), the global teleradiology market is expected to surpass a valuation of US$ 5.15 Bn through 2021. Favored by the increasing number of medical imaging procedures such as computed tomography (CT) scans and X-ray scans, the sales of teleradiology are likely to surge at a vigorous 12.18% CAGR during the assessment period.

Rising prevalence of diseases such as cancer, arthritis, cellulitis, and osteomyelitis are facilitating the market growth. According to the National Institute of Cancer, around 1898,160 new incidences of cancer are estimated to be diagnosed in 2021, causing approximately 608,570 deaths in the U.S.

As teleradiology enables the transfer of radiological images to qualified radiologists for providing effective treatments, it plays a life-saving function for patients. Thus, with the increasing number of cancer cases and lack of availability of skilled radiologists in sub-urban and rural areas, the demand for teleradiology systems is likely to increase over the coming year.

The coronavirus outbreak has favored the teleradiology market by increasing demand for medical imaging procedures across the globe. As the use of teleradiology systems avoids in-person contacts for the exchange of hard imaging result copies, these systems are increasingly being adopted by hospitals, medical institutes, and clinics for sharing study observations and details information gathered, thereby, driving teleradiology sales.

Get a Free Sample Copy of the Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-1747

“Key players in the market are integrating novel technologies such as artificial intelligence (AI), cloud-based solutions, and picture archiving and communication system (PACS) for developing innovative teleradiology solutions as they aim at capitalizing on the increasing demand of accurate diagnosis,” says the FMI’s analyst.

Key Takeaways from FMI’s Teleradiology Market Study

Sales of teleradiology systems are expected to rise at 9.10% between 2020 and 2021.

  • The U.S. is estimated to dominate the North America teleradiology market owing to the presence of leading market players in the country.
  • China is likely to emerge as the prominent market in Asia Pacific due to the high prevalence of chronic diseases such as cancer and arthritis.
  • Based on modality, CT scans are anticipated to lead the segment, on the back of rising digitalization and technological advancements in the segment.
  • Owing to the surging demand for diagnostic imaging procedures due to the lack of qualified radiologists, ambulatory imaging centres (AICs) are expected to account for substantial revenue share.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-1747

Competitive Landscape

Teleradiology Solutions, Argus Radiology, SRL Diagnostics, USARAD Holdings, Inc., Vital Radiology Services, and Telemedicine Clinic are the leading players operating in the teleradiology market as profiled by FMI.

The teleradiology market is highly fragmented owing to the presence of large number of market players. Leading player emphasizing on launching the new products and expanding their product portfolio to gain competitive edge over other player. Besides, this some of the players are adopting strategies such as strategic collaboration, merger, acquisition, and partnership with other industry players to strength their market footprint. For instance,

  • In February 2021, Medica Group, teleradiology provider headquartered in the U.K. announced entering in a joint venture partnership with MedX, a Canada-based pharmaceutical logistics and supply chain company. The strategy will help the Medica Group providing teleradiology reporting service in New Zealand, Australia, and Ireland
  • Recently Vital Radiology Services, an international teleradiology service provider company headquartered in India, announced entering into a partnership with one the largest medical imaging providers in the world, I-MED Radiology Network. This partnership will assist both the companies to bring innovation in the domain to a new level.

Get Customization in the Report, Enquire Now @ https://www.futuremarketinsights.com/customization-available/rep-gb-1747

More Insights into the Teleradiology Market Report

In its latest report, FMI offers an unbiased analysis of the global teleradiology market, providing historical data for the period of 2016-2020 and forecast statistics for the period of 2021-2031. In order to understand the global market potential, its growth, and scope, the market is segmented on the basis of modality (X-Ray scans, CT scans, MRI scans, ultrasound scans, nuclear scan, cardiac echo, mammography, and electromammography), and end user (hospitals, clinics, ambulatory surgical centres, and radiology centres), across U.S. and Other than U.S. (Latin America, Europe, Asia Pacific excluding Japan, Japan, and Rest of the World)

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact:
Future Market Insights,
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com/

Injectable Drug Delivery Market Size Revenue Forecast Worldwide From 2022 To 2028

According to the latest report published by Future Market Insights, titled ‘Global Injectable Drug Delivery Market: Global Industry Analysis 2013–2017 and Opportunity Assessment, 2018–2028’, the Global injectable drug delivery market is expected to expand at a CAGR of 10.9% over the forecast period, 2018–2028.

FMI estimates that the global market for Injectable Drug Delivery was valued at US$ 10,400.0 Mn in 2017 and is expected to expand at CAGR of 10.9% over 2018–2028, to reach US$ 32,136.9 Mn by 2028 end. Based on product type, the needle-free injectable drug delivery segment dominated the global injectable drug delivery market in 2017. Moreover, the subtype, prefilled of needle-free injectors segment is expected to have a dominant share of the needle-free type of injectable drug delivery market due to its ease of application. North America is expected to maintain its dominance in the global injectable drug delivery market due to the presence of a large number of manufacturers of injectable drug delivery devices, mostly operating from the U.S.

Increase in prevalence of chronic diseases such as diabetes, cancer and rheumatoid arthritis along with other factors such as need for patient-controlled drug release and increased risk of needle stick injuries are the prominent factors expected to drive the growth of the injectable drug delivery market. Technological advancements have resulted in better product offerings in the injectable drug delivery market. However, some factors such as strict regulatory framework and premium pricing of products are expected to hinder the growth of the injectable drug delivery market. The key trend of the injectable drug delivery market is the increasing demand for point-of-care devices. Injectable drug delivery devices are easy to self-administer and do not require a healthcare professional for administration, which as a result skips the need of hospital visits and relatively lowers the healthcare spending for an individual.

To remain ‘ahead’ of your competitors, request for a sample-  https://www.futuremarketinsights.com/reports/sample/rep-gb-393

The global injectable drug delivery market has been segmented on the basis of product type, usage, end users and regions. The disposable injectable drug delivery segment is expected to be the most attractive usage segment. Among the three end users, the hospital pharmacies is expected to be the dominant segment due to benefits such as favourable reimbursement policies in most of the countries across the globe.

In terms of value, the global injectable drug delivery market is expected to expand at 10.9% CAGR over the forecast period. With nearly 32% market share, North America was a dominant regional market for injectable drug delivery in 2017, due to growing number of manufacturers in the region and early adoption of new technologies. Western Europe is expected to be the second large market in injectable drug delivery, with Germany, the U.K. and France occupying major shares. APEJ is expected to be third large market for injectable drug delivery, due to requirement of low capital for manufacturing injectable drug delivery.

Get a Customized Scope to Match Your Need Ask an Expert-  https://www.futuremarketinsights.com/ask-question/rep-gb-393

Key Research Findings

  • Increase in demand for point-of-care devices and reduced reliance on healthcare facilities are driving the growth of the global injectable drug delivery market
  • North America will be the dominant regional market for injectable drug delivery devices due to early adoption of advanced technologies
  • Most of the major players operate from the U.S., which makes the U.S. the leading market for injectable drug delivery devices in North America
  • In Europe, a large number of diabetes patients are switching towards needle-free injectable drug delivery devices from conventional injections since it is a painless process and reduces the risk of needle stick injuries
  • Disposable injectors are the most commonly available type of injectors since they are user friendly and do not require special skills for administration
  • Prefilled needle-free injectors are the most preferred type of injectors since they are much easier to administer than the fillable type
  • Price control for most of the injectable drug delivery devices is fierce. For instance, Mylan was pressurised to launch the generic version of the EpiPen to reduce the price of the product in the market. However, this has declined the revenue of the company.
  • In developed regions, such as North America and Europe, hospitals are the dominant distribution channel due in injectable drug delivery due to the reimbursement policies
  • The growing competition in the emerging market and the rising demand for injectable drug delivery are the future opportunities for the growth and expansion of the injectable drug delivery market.

Examples of some of the key players identified in the global injectable drug delivery market include Amgen Inc., Medtronic PLC, West Pharmaceutical Services, Yepsomed, Becton, and Dickinson And Company, Antares Pharma, Mylan, SHL Group, Endo International PLC, Crossject, and Consort Medical (Bespak), among others.

Get Going with TOC Of Market Report- https://www.futuremarketinsights.com/reports/injectable-drug-delivery-market/table-of-content

Reasons to Buy the report

  • We provide authentic and detailed an analysis on various market trends to enable businesses to make informed and beneficial decisions to attain competitive edge over key players.
  • Our analysts provide detailed market segmentation along with meaningful insights and extensive reports that other companies fail to include.
  • The report includes accurate analysis of the market and the current developing trends affecting the growth. FMI speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, industry experts. This ensures that the data collected is from highly reliable sources.

For in-depth competitive analysis, Buy Now- https://www.futuremarketinsights.com/checkout/393

About FMI

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Mycobacterium Tuberculosis Testing Market Focusing on Current Trends, Leading with Top Key Players

Future Market Insights (FMI) adopted a multidisciplinary approach during the pandemic-era to focus on the growth and development of the Mycobacterium Tuberculosis Testing Market. The study features insights on the current growth dynamics and the major revenue reforms prevailing in the market as of 2020 along with the key takeaways over the forecast period.

Impact of COVID-19 on the Healthcare Industry

The COVID-19 pandemic has caused severe impacts on the global economy at various levels and which can be seen on the Healthcare industry as well. The thriving market of health care research and development is expected to exhibit a steep decline in the sales during the lockdown period owing to the shutdown of the manufacturing units, acute shortage in the supply of raw materials and absence of potential manpower. It can be deduced from the current situations brought about by the pandemic that the production, and supply chain activities have experienced minor hurdles. However, the market is projected to gradually recover post-COVID-19, which will present attractive opportunities for sales across various regions of the world in the following years.

The team of analysts at Future Business Insights are focussing on research and market study to produce different Mycobacterium Tuberculosis Testing Market forecasts and predictions at both national and international levels. They have considered several leads of information pertaining to the industry like market figures and merger estimations to assess and produce reliable and informative insights on the Mycobacterium Tuberculosis Testing Market.

Ask an Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-10259

Key Players

The major players operating in mycobacterium tuberculosis testing market are Thermo Fisher Scientific, Cepheid Inc. (Danaher Corporation), Medical Innovation Ventures Sdn. Bhd (Mediven), ELITechGroup, DAAN Gene Co., Ltd, AccuQuik, RTA Laboratories, Osang Healthcare CO., Ltd, Hologic, Inc., F. Hoffmann-La Roche AG., Abbott Laboratories, Novacyt Group, and Akonni Biosystems Inc..

Segmentation

Based on test type, the mycobacterium tuberculosis testing market is segmented into

  • Culture Based Tests
  • Nuclear Acid Amplification Tests
  • GeneXpert MTB/RIF 11
  • Line Probe Assay (LPA) 13
  • Loop-Mediated Isothermal Amplification (LAMP)
  • Smear Microscopy
  • Mantoux Test or Tuberculosis Skin Test
  • Interferon Gamma Release Assays (IGRAs)
  • Point of Care Test
  • Others

Based on end-user, the mycobacterium tuberculosis testing market is segmented into

  • Hospitals
  • Specialty Clinics
  • Diagnostic Laboratories
  • Others

Queries Solved

  • What is the size of the overall Mycobacterium Tuberculosis Testing Market in the Healthcare Industry and its segments?
  • What are the key segments and sub-segments in the market?
  • What are the key drivers, restraints, opportunities, and challenges of the Mycobacterium Tuberculosis Testing Market in the Healthcare Industry, and how they are expected to impact the market?
  • What are the attractive investment opportunities within the Mycobacterium Tuberculosis Testing Market in the Healthcare Industry?
  • What is the Mycobacterium Tuberculosis Testing Market in the Healthcare Industry size at the regional and country-level?
  • What are the key market players focusing on?
  • What are the strategies for growth adopted by the key players in Mycobacterium Tuberculosis Testing Market in the Healthcare Industry?
  • What are the recent trends in Mycobacterium Tuberculosis Testing Market in the Healthcare Industry? (M&A, partnerships, new product developments, expansions)?
  • What are the challenges to the Mycobacterium Tuberculosis Testing Market in the growth of the Healthcare Industry?
  • What are the key market trends impacting the growth of the Mycobacterium Tuberculosis Testing Market in the Healthcare Industry?

Ask for TOC @ https://www.futuremarketinsights.com/toc/rep-gb-10259

Reasons to buy the report

  • We provide authentic and detailed an analysis on various market trends to enable businesses to make informed and beneficial decisions to attain competitive edge over key players.
  • Our analysts provide detailed market segmentation along with meaningful insights and extensive reports that other companies fail to include.
  • The report includes accurate analysis of the market and the current developing trends affecting the growth. FMI speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, industry experts. This ensures that the data collected is from highly reliable sources.

Explore Wide-ranging Coverage of FMI’s Healthcare Market Insights Landscape

Th17 Driven Disease Treatment Market FMI’s analysis gives an insight into key market trends, strategies, regional players and various segments on the basis of form, type, application and region.

Transesophageal Echocardiography (TEE) Market Find insights into global market scenario and segmentation on the basis of ingredients, application, source and region.

Vascular Dressings Market FMI’s report highlights parent market trends and strategies in the market with segments and dynamics through the forecast period.

About us 

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact us

FMI
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com

Microbial Therapeutic Products Market Brief Forecast and Analysis by Top Key Players to 2030

Future Market Insights’ (FMI) global microbial therapeutic products report provides an exhaustive yet unbiased analysis of future growth projections, taking into account the aforementioned developments to provide a bird’s eye view of the landscape. According to the study, demand for microbial therapeutic products is likely to grow at a steady clip, driven chiefly by growing incidence of antimicrobial resistance.

Over the years, the burden of antimicrobial resistance (AMR) has been escalating tremendously, besides prevalence of chronic conditions. The World Health Organization observes high resistance rates have been observed against antimicrobials used for treating urinary tract infections and certain types of diarrhea. For example, the rate of resistance to ciprofloxacin ranged anywhere between 8.4% and 93% across 33 countries. It is apprehended that this burden is compounding further due to the COVID-19 pandemic. Hence, efforts are underway to accelerate research for discovering breakthroughs in microbial therapeutics.

Download FREE Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-12891

Key Takeaways

  • By product, anti-cancer agents to capture nearly 30% revenue by 2020-end, owing to prolific research breakthroughs
  • By route of administration, injection pens to account for 2 out of 5 sales, attributed to patient hygiene concerns
  • By source, bacteria based microbial therapeutic products to remain preferred
  • Oncology to remain primary microbial therapeutic products application area, expanding at Y-o-Y rate exceeding 5% through 2020
  • Hospitals emerge as the primary microbial therapeutic end-users, attributed to availability of adequate infrastructure
  • North America to remain the market hegemon, East Asia to be fastest growing market

“Prominent manufacturers are seeking regulatory approvals to accelerate research and development operations for developing effective drug solutions to address the compounding antimicrobial resistance problems,” remarks the FMI analyst.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-12891

COVID-19 Impact Analysis

The COVID-19 pandemic has adversely impact global economic outlook, with a prolonged recession on the cards across numerous industries. However, the microbial therapeutic products market has only stood to benefit from the pandemic crisis, as the global healthcare community accelerates efforts to find a potential cure for this deadly virus.

With inoculation procedures already being initiated across the U.K., it is only a matter of time before the anti-COVID-19 vaccine is available on a global scale. Despite this availability, healthcare providers will have a long road ahead with respect to discovering an orally administered drug formulation.

Therefore, governments are lending unconditional support to the global healthcare fraternity in terms of policy relaxation and disbursement of financial grants to aid in the research and development process, catapulting growth prospects.

Competitive Landscape

Prominent players operating in the global microbial therapeutic products market are emphasizing on acquiring regulatory approvals, forging partnerships and collaborations with competent authorities and biosimilars develop to capture substantial revenue shares across key regions.

Some reputed players operating within the global microbial therapeutic products landscape include Dr. Reddy’s Laboratories, Pfizer Inc., Sanofi SA, Merck & Co. Inc., Novartis AG, Novo Nordisk A/S, Abbott Laboratories and Amgen Inc. to name a few.

In November 2020, Dr. Reddy’s Laboratories announced a definitive agreement with Glenmark Pharmaceuticals Ltd. to acquire its anti-allergy brands Momat Rino, Momat Rino Advance and Momat A to market them across Russia, Kazakhstan and Uzbekistan respectively.

In December 2020, Novo Nordisk announced the acquisition of Emisphere Technologies to exercise ownership of its Eligen SNAC oral delivery technology. The acquisition shall accelerate its GLP-1 receptor agonist seaglutide’s production on a larger scale.

Feel free to ask your queries at https://www.futuremarketinsights.com/ask-question/rep-gb-12891

More Valuable Insights on FMI’s Microbial Therapeutic Products Market

Future Market Insights, in its new report, offers an unbiased analysis of the global microbial therapeutic products market, analyzing historical demand from 2015-2019 and forecast statistics for 2020-2030. The study reveals growth projections on the microbial therapeutic products market on the basis of product (growth factors, anti-cancer agents, immunosuppressants, enzymes & others), route of administration (single use pre-filled injection/injection pen, multi-use injectors & others), source (bacteria & fungi), application (metabolic disorders, haematological disorders, oncology, immunological disorders, infectious diseases, allergic diseases & others) and end-user (hospitals, pharmaceuticals & biopharmaceutical companies and research & academic institutions) across seven prominent regions.

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact:
Future Market Insights,
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com/

Canine Arthritis Treatment Market : The Trends Driving Growth And Shaping The Future 2029

A notable increase in dog ownership around the world, developing veterinary healthcare infrastructure and rising treatment options for canine arthritis are the key factors for the growth of the global canine arthritis treatment market.

As per the findings of Future Market Insights, the global canine arthritis treatment market is projected to experience significant growth during the forecast period, due to increasing prevalence of obesity induced arthritis among dogs and rise in awareness about the companion animal health. Moreover, ease in the FDA approval for novel and innovative canine arthritis treatment drugs will create growth opportunities for the market players.

To remain ‘ahead’ of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/REP-GB-3552

The global canine arthritis treatment market valued in 2019 is estimated at ~ US$ 1.9 Bn, and is expected to increase at a CAGR of ~ 4% during the forecast period of 2019-2029.

Key Takeaways from Canine Arthritis Treatment Market Study

– Non-steroidal anti-inflammatory medications are referred as a first choice of veterinarian for the treatment of inflammation and pain. These medications are known to have effects, for example, decreasing tingling, allergic reaction, swelling, and pain. Canines approved non-steroidal anti-inflammatory medications have demonstrated acceptable safety profile, which is in contrast to non-approved NSAIDs.
– Growth prospects of the canine arthritis market are relatively high in North America as compared to other regions, attributed to rise in the adoption rate of canines, increasing veterinary expenditure on their health, and greater awareness about the pet health.
– Market players remained focused on capitalizing on veterinary hospitals and clinics, as they provide an entire animal care and service support for better pet health.
– Oral formulations of major non-steroidal anti corticosteroids medications will continue to account for major share of the manufacturers’ bottom lines, in the view of increasing demand for their ease of administration and better animal compliance.

For critical insights, request for PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-3552

Robust Clinical Development Pipeline to Dictate Stakeholders’ Strategies

Elanco, Ceva Sante Animale, Boehringer Ingelheim are among the leading players in the canine arthritis treatment market. These manufacturers continue to dominate the market landscape of canine arthritis treatment by ensuring product availability, collaborating with the local distributors, strengthening manufacturing facilities, and strategizing R&D for diversification of product portfolio.

What did Analysts Uncover during the Study?

A comprehensive view of the canine arthritis treatment market has led our analysts to conclude that, the market is growing at an impressive rate, with North America and Europe holding a large share of the global canine arthritis treatment market. Increase in the pet adoption rate in developed economies, increase in the disposable expense on the companion animals, and rise in awareness regarding pet health are anticipated to propel the market growth.

Read Full Report – https://www.futuremarketinsights.com/reports/canine-arthritis-market

About FMI:

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.